AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2015
Feb 24, 2015
30403_dirs_2015-02-24_634d4943-eb95-4ffe-a31d-c3182926d271.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2015-02-20
Reporting Person: Balousek Jon M (SVP - GM, Specialty Div)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-20 | Common Stock | M | 13940.0000 | $66.4800 | Acquired | 23069.0000 | Direct |
| 2015-02-20 | Common Stock | M | 12150.0000 | $68.1500 | Acquired | 35219.0000 | Direct |
| 2015-02-20 | Common Stock | M | 8240.0000 | $57.2500 | Acquired | 43459.0000 | Direct |
| 2015-02-20 | Common Stock | S | 29663.0000 | $109.1024 | Disposed | 13796.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-20 | Stock Option (Right to Buy) | $68.1500 | M | 12150.0000 | Disposed | 2021-09-13 | Common Stock (12150.0000) | Direct |
| 2015-02-20 | Stock Option (Right to Buy) | $66.4800 | M | 13940.0000 | Disposed | 2020-09-14 | Common Stock (13940.0000) | Direct |
| 2015-02-20 | Stock Option (Right to Buy) | $57.2500 | M | 8240.0000 | Disposed | 2019-09-15 | Common Stock (8240.0000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $109.00 to $109.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29